Latest Manufacturing News

Zoono Group has signed a five-year exclusive contract with Multisteps Pty Limited to apply its antimicrobial technology to fresh produce packaging in Australia, aiming to reduce food waste and boost sustainability.

Wagners Holding Company Limited has reported a strong start to FY26 with robust demand across its construction materials and composite fibre technologies segments, prompting an upgrade to its EBIT guidance.

Wagners Holding Company Limited reported a strong FY25 with profits more than doubling, driven by robust construction demand in Southeast Queensland and growth in composite fibre technologies. The company raised $30 million to expand its concrete plants and composite production capacity, positioning for further growth in FY26.

Vulcan Energy has appointed ABB as the main electrical contractor for its flagship Lionheart lithium project, marking a significant step towards financing and construction. The €46 million fixed-price contract covers comprehensive electrical infrastructure for a facility set to produce enough lithium for 500,000 electric vehicles annually.

Synlait Milk Limited has temporarily expanded its banking facilities by NZ$50 million to manage ongoing cost impacts from earlier manufacturing challenges, while preparing to reduce debt through a major asset sale.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

Trek Metals has announced a breakthrough discovery of exceptionally high-grade manganese at its Christmas Creek Project in Western Australia, with assays revealing grades up to 58%. This greenfields find hints at a potentially large hydrothermal manganese system yet to be drill tested.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.

Anteris Technologies Global Corp. reported a $22.2 million loss in Q3 2025 while progressing its DurAVR Transcatheter Heart Valve pivotal trial following key regulatory approvals. The company bolstered its cash position with a $25.2 million private placement post-quarter.

Temas Resources has completed 1,000m of a 2,500m diamond drilling program at its La Blache project in Quebec, targeting expansion of titanium and critical minerals resources. Early signs of gallium and scandium add to the project's potential value.

EBR Systems has achieved a major commercial milestone with Medicare reimbursement approvals for its wireless cardiac pacing WiSE CRT System, driving a 201% revenue increase in Q3 2025. The company is advancing its Limited Market Release as it scales adoption in the US.